Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00558012 · ClinicalTrials.gov registry record · NA
Zoledronic Acid for Osteoporosis in the Elderly
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
NCT00558012 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 181 participants.
The verdict
NCT00558012, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
Study Summary
This trial will examine the safety, efficacy and feasibility of a single dose of intravenous zoledronic acid in the maintenance of skeletal integrity for frail, institutionalized women, who are most at risk for the deleterious outcomes of osteoporosis. The investigators will test the hypothesis that in institutionalized elderly women a single dose of intravenous zoledronic acid therapy will: (1) be efficacious as demonstrated by stability or improvement in bone mass measurements and reductions in bone turnover; (2) be safe and feasible; and (3) provide estimates for vertebral and nonvertebral fracture reduction in this cohort for use in planning a future study.
Interventions
- DRUG Intravenous zoledronic acid
- DIETARY_SUPPLEMENT Vitamin D 800 IU/daily
- DIETARY_SUPPLEMENT Calcium 1200 mg/daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2007-12 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00558012
The ClinicalTrials.gov registry entry for NCT00558012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intravenous zoledronic acid is the first listed.
NCT00558012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00558012 about?
NCT00558012 is a clinical study titled "Zoledronic Acid for Osteoporosis in the Elderly". This trial will examine the safety, efficacy and feasibility of a single dose of intravenous zoledronic acid in the maintenance of skeletal integrity for frail, institutionalized women, who are most at risk for the deleterious outcomes of osteoporosis. The investigators will test the hypothesis that...
What is the current status of trial NCT00558012?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2007-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00558012?
The interventions under investigation include: Intravenous zoledronic acid (DRUG), Vitamin D 800 IU/daily (DIETARY_SUPPLEMENT), Calcium 1200 mg/daily (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00558012?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.